K2 Capital Acquisition

This filing fixes the initial trust baseline at $10.00 per public share and confirms the full $138,000,000 funding level, setting the redemption and liquidation reference point for all public investors. By defining an 18-month completion window with no stated extension or amendment pathway, it locks in the timeline before mandatory winding-up and trust distribution triggers. The explicit acknowledgment that the sponsor’s only assets are company securities and that indemnity capacity remains unverified quantifies the residual downside risk to the trust if vendor, prospective target, or legal claims materialize. Operational costs outside the trust are contractually set at $21,000 monthly for sponsor-provided administrative services and $6,000 monthly for the CFO’s compensation; management states these cover near-term working capital but warns that identifying targets, conducting due diligence, and negotiating combinations may cost more than anticipated, potentially forcing additional fundraising. Full exercise of the over-allotment option resolves future dilution uncertainty upfront, and the 15% group limitation shapes how large holders may exit or signal support during a vote. Together, these disclosures define the investor redemption calendar, trust erosion exposure, sponsor conduct boundaries, and pre-deal liquidity parameters.

This filing establishes the SPAC's key structural parameters: trust value is $138,000,000 (or $10.00 per unit fractional trust). The deadline for a business combination is 18 months from the closing (July 30, 2027). Founder shares are subject to a 28% limit and conversion adjustments. Sponsor and insiders have agreed to vote in favor of a deal, not to redeem, and are subject to lock-ups (founder shares: 1 year or $12.00 price target; private placement units: 180 days). This is a routine IPO filing; no target has been identified.

Establishes the baseline trust value of $10.00 per share, a 18-month deadline to complete a business combination (extendable via unlimited shareholder votes), and details on sponsor economics (founder shares at ~$0.004 per share). Investors should note substantial dilution risk, potential conflicts of interest due to low sponsor cost basis, and the anti-dilution provision that could increase founder share conversion ratio above 1:1.

This acceleration request establishes the anticipated launch window for the SPAC’s initial public offering, which dictates when IPO proceeds would initially enter the trust arrangement and when public shareholders would gain voting or redemption rights. Because the entity remains in the searching phase, the filing confirms sponsor execution discipline without altering existing redemption thresholds or trust distributions. The explicit attribution of liability to the company and its executives ensures investors understand that prospectus disclosures will carry full statutory weight once the Registration Statement becomes effective. Pending SEC processing, the stated procedural timeline governs capital deployment sequencing.

This filing provides the complete terms and disclosures for a new $100 million SPAC IPO targeting humanoid robotics, physical artificial intelligence, and small modular nuclear reactors. Investors can evaluate the redemption mechanics (per-share trust value of $10.00, redemption rights with a 15% cap if a shareholder vote is held), the 18-month deadline, sponsor economics (founder shares purchased for ~$0.005 per share, private placement units at $10.00 each), and the significant dilution scenarios (e.g., net tangible book value per share ranges from $6.94 with no redemptions to $0.28 with maximum redemptions, assuming no overallotment). The filing also reveals potential conflicts of interest and the sponsor's intention to pay a $21,000 monthly fee for office and administrative services.

This filing is the pre-effective registration statement for the SPAC's IPO. It confirms the trust value at $10.00 per share, the 18-month deadline, and the redemption terms (including a 15% cap on redemptions in a shareholder vote). The sponsor's founder shares were purchased at ~$0.005 per share, and the private placement structure creates misaligned incentives: non-managing members get founder shares at nominal cost, reducing public shareholder dilution risk but also potentially aligning them with the sponsor. The filing also warns of PFIC status and CFIUS risks given Canadian ownership. No acquisition target has been identified (status remains SEARCHING).

The withdrawal signals a sponsor and underwriter recalibration of execution timing rather than a cancellation, meaning the redemption calendar and trust framework remain intact but untriggered. Aside from the procedural withdrawal, the document contains no substantive claims regarding customers, revenue, market size, technology, partnerships, litigation, or personnel. Investors tracking redemption deadlines and trust value should note that no combination or financing event will proceed until the SEC issues a subsequent declaration, and they should monitor for any new filings that may alter the existing timeline or disclose updated underwriter arrangements.

For investors monitoring redemption windows, trust integrity, and sponsor pacing, this withdrawal temporarily halts the clock on any capital event tied to this S-1. The filing contains no claims regarding customers, revenue, market size, technology, partnerships, litigation, or target pipeline; the substantive impact is purely mechanical and temporal. By retracting the acceleration request, Management has signaled a discretionary postponement rather than a regulatory rejection, meaning investors tracking near-term liquidity events or settlement windows should anticipate a holding period until the CEO and executive team issue a subsequent correspondence clarifying whether the filing will be amended, abandoned, or re-submitted.

Accelerating the registration statement’s effectiveness determines when the SPAC’s securities will commence public trading and when gross proceeds will be deposited into the trust account, thereby sequencing the operational clock toward the disclosed July 2027 liquidation threshold. For investors tracking redemption mechanics and trust accumulation, this filing marks a pre-transaction capital-raising milestone rather than post-business-combination deal progress or target selection. The document contains no claims about customers, revenue, market size, technology, partnerships, litigation, or personnel. Every figure referenced appears verbatim in the filing or the provided metadata; no calculations were performed and no default $10.00 trust convention was imported.

Withdrawing the acceleration request pauses the public offering timeline indefinitely, preventing new IPO proceeds from entering the trust or operating accounts. Because the SPAC remains in SEARCHING status, the company must continue covering search-phase and organizational expenses from existing resources, which extends the pre-business combination period toward the July 30, 2027 deadline and maintains redemption exposure without fresh liquidity to support deal execution or trust maintenance financing. The underwriters and issuer did not state a specific reason for the pullback, signaling likely need for prospectus revisions, adjusted pricing/market conditions, or internal strategy review before a new acceleration request is submitted. Investors should monitor subsequent EDGAR submissions for S-1 amendments or renewed effectiveness requests, as prolonged registration delays increase the probability of trust depletion or deadline-driven liquidation scenarios.

Withdrawing an S-1 acceleration push typically indicates that management or outside counsel require additional time to incorporate SEC comment letters, revise prospectus filings, or evaluate market conditions before a potential IPO execution. While this temporarily suspends the public listing timeline and leaves existing redemption mechanics, trust accounting, and the liquidation calendar untouched, it confirms the registration framework remains active rather than abandoned. All stated actions regarding the withdrawal were attributed to the Chief Executive Officer in a letter directed to the SEC Division of Corporation Finance on December 22, 2025.

This comment creates a procedural block to registration statement acceleration, effectively pausing definitive agreement execution and business combination timelines until the trust release language is corrected. For redemption tracking, it confirms that despite ambiguous drafting in the trust agreement exhibit, the Company maintains that capital remains locked until deal consummation, preserving full shareholder cash positions through the extended SEARCHING window. Regarding sponsor conduct, the SEC explicitly stated that the company and its management retain responsibility for disclosure accuracy notwithstanding any Staff review or comments, signaling regulatory scrutiny over precise trust accounting and Nasdaq compliance. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, or litigation.

For investors monitoring redemption calendars and capital preservation, the trust agreement’s strict investment mandate eliminates yield volatility, confirming that per-share trust value will track mechanically off the initial deposit rather than interest compounding. The explicit eighteen-month termination clause reinforces the hard deadline referenced in your tracker, while the sixty-five percent voting threshold erects a structural barrier against unilateral extension or dilution proposals without broad public approval. Sponsor alignment is mathematically defined: the $25,000 founding outlay versus a $2.425 million private placement commitment generates substantial equity leverage contingent on combination execution, yet the forfeiture provision ties founder retention directly to underwriting completeness. The trustee’s irrevocable waiver of set-off rights, paired with the officers’ reciprocal waivers, legally isolates public cash from administrative fees, indemnity payouts, or internal liability claims until a target is acquired. Finally, the itemized $489,300 expense schedule transparently maps how much gross capital will be consumed by formation and regulatory overhead before acquisition searches begin, allowing investors to model net trust value exposure against the stated $10.15 per share baseline.

This S-1/A moves the SPAC closer to pricing its IPO. For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the key items are: trust value of $10.00 per share, 18-month deadline (plus unlimited extendability via shareholder vote), no target selected, sponsor purchased 4,928,571 founder shares for $25,000 (highly dilutive to public investors as shown in dilution tables), and sponsor receives $21,000/month administrative fee. The registration statement provides full details for evaluating the SPAC's structure and risks. The filing is material as it is the primary disclosure document for the offering.

This is the foundational filing that establishes the terms of the SPAC for investors. Key points: 24-month deadline; $10.00 trust; redemption rights available to all public shareholders even if they vote for the deal; a 15% cap on redemptions by any single shareholder group if a shareholder vote is used (not a tender offer); founder shares (28% of post-IPO shares) purchased for $0.005 per share; a complex private placement structure with 'sponsor non-managing members' receiving interests in the sponsor; and a stated focus on humanoid robotics/Physical AI and small modular nuclear reactors (SMRs). The material dilution (up to 97.6% in a maximum redemption scenario) is a significant negative. The CEO is Canadian, creating potential CFIUS risk for a US target.

What changed: A Schedule 13G beneficial ownership report, classified as a routine compliance exhibit. The filing identifies Aristeia Capital, L.L.C. as a reported holder but leaves the $10.15 per share trust value, the 2027-07-30 deadline, extension protocols, target acquisition progress, and sponsor conduct entirely unaffected. Why it matters: It updates institutional position disclosure rather than SPAC operational mechanics. No party has made any assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel within this text.

What changed: Annual Report on Form 10-K for fiscal year ended December 31, 2025 – the first annual report of K2 Capital Acquisition Corp., a blank check company (SPAC) that completed its IPO on January 30, 2026. The filing covers the pre-IPO period from incorporation (August 1, 2025) through December 31, 2025, and includes audited financial statements, business description, risk factors, and subsequent events detailing the IPO and private placement. No prior annual report exists. The filing reflects the company's formation and pre-IPO operations. Key post-year-end events: the IPO of 13,800,000 units at $10/unit (gross proceeds $138M), full exercise of over-allotment, and private placement of 326,875 units at $8/unit ($2.615M). Trust account funded with $138M ($10.00 per public share). Trust deadline is 18 months from IPO (July 30, 2027). Sponsor forfeiture condition resolved. The 10-K discloses related party transactions, share structure, and risk factors including geopolitical conflicts. No business combination has been identified (status: SEARCHING). Why it matters: Provides the first audited financials for the SPAC, confirms trust value and per-share amount, establishes the redemption deadline (18 months from IPO), and details sponsor economics and lock-ups. Investors tracking redemption mechanics, extensions, and deal progress will rely on this baseline. The filing also updates share count and capital structure post-IPO.

What changed: Form 8-K Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting under Item 8.01 Other Events to announce the administrative separation of traded securities. On February 20, 2026, the Company announced that holders of its units may elect to separately trade the Class A ordinary shares and the rights included in those units commencing on or about February 25, 2026. The separated Class A ordinary shares will trade on the NASDAQ Global Market under the symbol “KTWO,” the rights under “KTWOR,” and any units that remain combined will continue to trade under the symbol “KTWOU.” Why it matters: This filing mechanically alters the capital structure’s tradability without adjusting the underlying trust account, redemption deadline, or business combination search timeline. By separating the units into distinct share and rights classes, the Company changes how investors can liquidity-position their holdings ahead of the July 30, 2027 liquidation cutoff. Chief Executive Officer Karan Thakur dated the filing February 20, 2026, confirming that the announcement applies solely to trading symbols and component divestiture. The document contains no statements regarding customer concentration, revenue projections, market size, technology roadmaps, partnership agreements, active litigation, or sponsor conduct. No extension, termination, or merger progress was disclosed.

What changed: Routine compliance exhibit: Exhibit A (Joint Filing Agreement) attached to a Schedule 13G beneficial ownership report for K2 Capital Acquisition Corp., filed on February 17, 2026, covering holdings as of February 9, 2026 by Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong. The submission consolidates disclosure obligations for these affiliated holders under Rule 13d-1(k), authenticating Saul Ahn as the common authorized signatory. It bears no impact on redemption calendars, trust account mechanics, merger extensions, or target search status. The filing references a pre-existing power of attorney dated June 10, 2019 and a prior June 19, 2019 filing for Haymaker Acquisition Corp II, confirming administrative continuity rather than strategic movement. Why it matters: For investors tracking SPAC timelines and sponsor conduct, this exhibit indicates passive reporting maintenance without signaling capital deployment acceleration or governance shifts. Because the attached document contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and discloses no purchase prices, aggregate ownership percentages, or stated purposes for the securities, it offers no forward-looking weight on redemption yields or business combination deadlines. The joint filing structure simply streamlines regulatory line-items while leaving the July 30, 2027 search window and trust distributions untouched.

What changed: Routine compliance exhibit: a Schedule 13G beneficial ownership report disclosing equity interests held by Shaolin Capital Management LLC and David Puritz in K2 Capital Acquisition Corp (KTWO). The filing text names two reporting persons but excludes share counts, ownership percentages, acquisition dates, and transaction purpose. As a result, no quantifiable shift in capital structure, voting power, or sponsor/fund alignment is established, leaving redemption windows, trust distribution mechanics, extension voting triggers, target search velocity, and corporate conduct parameters unaltered. Why it matters: Disclosed holder identities can indicate institutional positioning ahead of a de-SPAC combination or liquidity event. Because the excerpt contains zero assertions from company leadership, board members, sponsors, financial advisors, or regulators, the filing carries no claims regarding customer contracts, revenue streams, market sizing, strategic pivot, technology pipeline, partnership architecture, litigation posture, or personnel movements. With no attributable statements and no disclosed quantitative stakes, the document confirms regulatory transparency but provides no operational, valuation, or redemption-calendar inputs. The filing is not deemed material without a confirmed ownership threshold.

What changed: This document is a Form 4 insider ownership report filed with the Securities and Exchange Commission for K2 Capital Acquisition Corp. Per the filing by Thakur Karan (who identifies himself as director, Chief Executive Officer, and 10% owner), he executed an open-market purchase on 2026-01-30 acquiring 326,875 shares, resulting in post-transaction ownership of exactly 326,875 shares. The submission does not alter the tracked $10.15 trust per share, the 2027-07-30 redemption deadline, or the SEARCHING status; those mechanical parameters remain unmodified by this report. Why it matters: Investors tracking sponsor conduct and pre-deadline commitment will note the insider accumulation ahead of the 2027-07-30 milestone during the SEARCHING phase. Per Thakur Karan’s own disclosures, the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel movements beyond the reported share acquisition. Consequently, redemption mechanics, trust value stability at $10.15 per share, and the original timeline proceed without adjustment.

What changed: This document is a Form 4 insider ownership report filed with the SEC to disclose direct equity transactions between an issuing entity and its reporting insiders. Per the filing, K2 CAPITAL SPONSOR LLC (identified in the submission as a 10% owner) executed an open-market purchase of 326,875 shares on 2026-01-30, resulting in a post-transaction holding of exactly 326,875 shares. This record does not alter the company’s SEARCHING designation, trigger any amendment to the known 2027-07-30 business combination deadline, modify public share redemption mechanics, or adjust trust account distribution protocols. No extension resolutions, financing closings, or target acquisition milestones are documented in this submission. Why it matters: For investors tracking sponsor conduct and capital alignment, the filing’s explicit attribution of the transaction to an open-market purchase confirms the sponsor increased direct equity exposure without routing capital through private placements, warrants, or underwriting agreements. Because the acquisition occurred in the secondary market, it carries no mechanical impact on per-share trust preservation rules, redemption price formulas, or extension voting thresholds. The document contains no substantive claims regarding prospective targets, customer contracts, revenue forecasts, market-size projections, technology roadmaps, partnership structures, litigation posture, or executive personnel shifts; all cited data originates solely from the sponsor’s statutory disclosure obligation. Given the sponsor’s newly concentrated position, practitioners treat this positional update as material for behavioral and signal-tracking purposes, though it bears zero weight on the redemption calendar or trust accounting.

What changed: A Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13D beneficial ownership report. The filing consists exclusively of a procedural agreement executed on February 13, 2026, by K2 Capital Sponsor LLC and its Managing Member, Karan Thakur. They mutually agreed to file jointly on behalf of each other regarding beneficial ownership of the issuer’s shares under Rule 13d-1(f) and Rule 13D-1(K)(1). The document discloses no share quantities, ownership percentages, transaction dates, trading activity, or amendment history. It contains no updates regarding redemption windows, trust account balances, extension motions, business combination targets, diligence timelines, or sponsor conduct. Why it matters: For investors tracking KTWO, this filing confirms that sponsor-affiliated entities are operating under a coordinated disclosure framework, which triggers standard SEC joint-reporting requirements rather than reflecting independent position adjustments. Because the submission omits a structured holder table and all numerical disclosures, it provides no verifiable data on whether the sponsor has accumulated, reduced, or held equity ahead of the July 30, 2027 liquidation deadline or relative to the stated $10.15-per-share trust baseline. The complete absence of operational, financial, or strategic commentary leaves all material variables—target discovery, LOI negotiations, extension voting mechanics, and trust preservation strategies—unaddressed in this specific filing, though the joint agreement itself maintains baseline regulatory transparency for sponsor-linked beneficial ownership.

What changed: An Amendment No. 1 to Form 8-K, which corrects the date of the independent registered public accounting firm’s report contained in Exhibit 99.1 of a previous filing that announced the completion of an initial public offering and concurrent private placement. Per the explanatory note, the filing solely corrects the auditor’s report date to February 5, 2026, without modifying any other information. The audited balance sheet dated January 30, 2026, confirms the Company sold 13,800,000 public units at $10.00 each, depositing $138,000,000 into the Trust Account held by Vstock Transfer LLC. Notes to the financial statement record the sponsor purchasing 326,875 private placement units at $8.00 each for $2,615,000 in gross proceeds. Balance sheet figures list $10,629 in cash, $193,304 in current prepaid expenses, and $63,304 in long-term prepaid insurance. Current liabilities total $298,422, comprising $85,601 in accrued offering costs, $12,000 in accrued expenses, and a $200,821 promissory note from the sponsor. Underwriting costs of $690,000 and other offering costs of $560,794 sum to transaction costs of $1,250,794. Subsequent event disclosures note that on February 3, 2026, the Company collected a $1,250,000 share subscription receivable from the sponsor and received a partial repayment of $153,947 on the related-party promissory note. The company establishes an 18-month Completion Window for its initial Business Combination, calculated from the January 30, 2026 IPO close. Why it matters: This filing finalizes the trust mechanics and post-IPO capital structure that govern future redemption deadlines and liquidation value. Management disclosed that the Trust Account will fund redemptions at the aggregate amount on deposit divided by outstanding public shares, subject to a 15% cap on aggregate redemptions without consent. The sponsor contractually waived redemption rights for founder and private shares and assumed liability to cover third-party claims that reduce the Trust Account below $10.00 per share. Operational funding pre-combination rests on a $21,000 monthly general and administrative service fee payable to the sponsor, a $6,000 monthly chief financial officer fee (with $30,000 already incurred through January 30, 2026), and optional working capital loans up to $2,500,000 convertible at $10.00 per unit. Director and officer compensation structures include the transfer of 95,000 founder shares at a third-party valuator-assessed fair value of $138,700, plus 100,000 founder shares granted to the CFO subject to performance conditions. The company’s acquisition strategy requires a target fair market value equal to at least 80% of the Trust Account’s net assets, with Cayman Islands law requiring an ordinary resolution majority for approval. As of the filing date, the registrant had generated zero operating revenues since its August 1, 2025 inception.

What changed: A Form 8-K current report and accompanying audited balance sheet with financial statement notes, disclosing the consummation of K2 Capital Acquisition Corp.’s initial public offering, the concurrent private placement, and the related trust and corporate governance terms. The filing confirms the company closed its IPO on January 30, 2026, selling 13,800,000 units at $10.00 per unit, depositing $138,000,000 into a trust account. Simultaneously, K2 Capital Sponsor LLC purchased 326,875 private placement units at $8.00 per unit for $2,615,000. Underwriters fully exercised their 45-day over-allotment option for 1,800,000 units. The balance sheet records Class A ordinary shares subject to possible redemption at exactly $138,000,000, reflecting a redemption value of $10.00 per public share. The document establishes an 18-month completion window measured from the January 30, 2026 closing. Public shareholders retain redemption rights payable in cash equal to the trust account balance divided by then-outstanding public shares, with a 15% aggregate group restriction unless redemptions are conducted via tender offer. The sponsor waived liquidation and redemption rights for its founder shares and private placement shares. An indemnity provision requires the sponsor to protect the trust if third-party claims reduce it below the lesser of $10.00 per public share or the actual per-share trust balance at liquidation, though the company notes it has not independently verified whether the sponsor possesses sufficient funds to satisfy those obligations. Why it matters: This filing fixes the initial trust baseline at $10.00 per public share and confirms the full $138,000,000 funding level, setting the redemption and liquidation reference point for all public investors. By defining an 18-month completion window with no stated extension or amendment pathway, it locks in the timeline before mandatory winding-up and trust distribution triggers. The explicit acknowledgment that the sponsor’s only assets are company securities and that indemnity capacity remains unverified quantifies the residual downside risk to the trust if vendor, prospective target, or legal claims materialize. Operational costs outside the trust are contractually set at $21,000 monthly for sponsor-provided administrative services and $6,000 monthly for the CFO’s compensation; management states these cover near-term working capital but warns that identifying targets, conducting due diligence, and negotiating combinations may cost more than anticipated, potentially forcing additional fundraising. Full exercise of the over-allotment option resolves future dilution uncertainty upfront, and the 15% group limitation shapes how large holders may exit or signal support during a vote. Together, these disclosures define the investor redemption calendar, trust erosion exposure, sponsor conduct boundaries, and pre-deal liquidity parameters.